1. Home
  2. GWAV vs UBX Comparison

GWAV vs UBX Comparison

Compare GWAV & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GWAV
  • UBX
  • Stock Information
  • Founded
  • GWAV 2002
  • UBX 2009
  • Country
  • GWAV United States
  • UBX United States
  • Employees
  • GWAV N/A
  • UBX N/A
  • Industry
  • GWAV Packaged Foods
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GWAV Consumer Staples
  • UBX Health Care
  • Exchange
  • GWAV Nasdaq
  • UBX Nasdaq
  • Market Cap
  • GWAV 12.6M
  • UBX 13.9M
  • IPO Year
  • GWAV N/A
  • UBX 2018
  • Fundamental
  • Price
  • GWAV $0.19
  • UBX $0.78
  • Analyst Decision
  • GWAV
  • UBX Strong Buy
  • Analyst Count
  • GWAV 0
  • UBX 3
  • Target Price
  • GWAV N/A
  • UBX $4.67
  • AVG Volume (30 Days)
  • GWAV 1.4M
  • UBX 521.0K
  • Earning Date
  • GWAV 08-18-2025
  • UBX 08-05-2025
  • Dividend Yield
  • GWAV N/A
  • UBX N/A
  • EPS Growth
  • GWAV N/A
  • UBX N/A
  • EPS
  • GWAV N/A
  • UBX N/A
  • Revenue
  • GWAV $33,315,859.00
  • UBX N/A
  • Revenue This Year
  • GWAV N/A
  • UBX N/A
  • Revenue Next Year
  • GWAV N/A
  • UBX N/A
  • P/E Ratio
  • GWAV N/A
  • UBX N/A
  • Revenue Growth
  • GWAV N/A
  • UBX N/A
  • 52 Week Low
  • GWAV $0.12
  • UBX $0.66
  • 52 Week High
  • GWAV $1.88
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • GWAV 47.09
  • UBX 48.12
  • Support Level
  • GWAV $0.19
  • UBX $0.67
  • Resistance Level
  • GWAV $0.20
  • UBX $0.83
  • Average True Range (ATR)
  • GWAV 0.01
  • UBX 0.09
  • MACD
  • GWAV -0.00
  • UBX 0.01
  • Stochastic Oscillator
  • GWAV 36.21
  • UBX 24.67

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: